Emphasis
The emphasis is on development of transformative machine intelligence-based systems, emerging tools, and modern technologies for diagnosing and recommending treatments for a range of diseases and health conditions. Unsupervised and semi-supervised techniques and methodologies are of particular interest.
Program priorities and areas of interest:
- clinical decision support systems
- computer-aided diagnosis
- computer-aided screening
- analyzing complex patterns and images
- screening for diseases
- natural-language processing and understanding
- medical decision-making
- predictive modeling
- computer vision
- robotic and image guided surgery
- personalized imaging and treatment
- drug discovery
- radiomics
- machine/deep learning-based segmentation, registration, etc.
Additional support
This program also supports:
- early-stage development of software, tools, and reusable convolutional neural networks
- data reduction, denoising, improving performance (health-promoting apps), and deep-learning based direct image reconstruction
- approaches that facilitate interoperability among annotations used in image training databases
Related News
A team of researchers at Vanderbilt University has developed a system of artificial cilia capable of monitoring mucus conditions in human airways to better detect infection, airway obstruction, or the severity of diseases like Cystic Fibrosis (CF), Chronic Obstructive Pulmonary Diseases (COPD) and lung cancer. The lead researcher was funded by an NIH/NIBIB Trailblazer Award. Source: Vanderbilt School of Engineering
NIBIB has designed an initiative called Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (eBEITA) at HBCUs. Recently, NIBIB made its first round of eBEITA grants to two HBCUs.
In a study published in Small, researchers at the University of Rochester outline a new method for using ultrathin membranes to easily identify extracellular vesicles for rapid liquid biopsies. The method, called catch and display for liquid biopsy (CAD-LB), holds promise for diagnosing cancer quickly and affordably, and assessing the progress of therapies used to treat diseases. Source: University of Rochester News
NIH has announced winners of the RADx® Tech Fetal Monitoring Challenge, a $2 million prize competition to speed development of innovative medical technologies for fetal health diagnosis, detection and monitoring.
Metastasis remains the primary challenge to reducing cancer deaths worldwide. Now, a study by Memorial Sloan Kettering, published in Nature is providing unique insights into metastasis that researchers say point to new therapeutic opportunities. Source: Memorial Sloan Kettering Cancer Center News